The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Aminoguanidine Ameliorates and l -Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery Occlusion
Abstract
Background and Purpose We studied whether the inducible nitric oxide synthase (iNOS) inhibitor aminoguanidine reduces focal cerebral ischemic damage in a relatively noninvasive stroke model in which the rat middle cerebral artery (MCA) is occluded using an intravascular filament. Methods In rats anesthetized with halothane, a nylon filament was advanced into the internal carotid artery until its tip occluded the origin of the MCA. The filament was left in place for 2 hours and then withdrawn. Twenty-four hours later, rats received intraperitoneal injections of aminoguanidine (100 mg/kg BID; n=7), aminoguanidine+ l -arginine (300 mg/kg QID; n=7), l -arginine alone (n=6), d -arginine alone (n=6), or vehicle (n=10). Drugs were administered for 3 consecutive days. Infarct volume was determined by image analysis in thionin-stained brain sections 4 days after ischemia. iNOS mRNA was detected with the use of reverse transcription polymerase chain reaction. Results Cerebral ischemia led to iNOS mRNA expression in the affected brain 48 hours after induction of ischemia. Administration of aminoguanidine reduced neocortical infarct volume by 26% ( P <.05 versus vehicle, ANOVA and Tukey’s test), a reduction that was antagonized by coadministration of l -arginine ( P >.05 versus vehicle). Administration of l -arginine alone, but not d -arginine, enlarged the infarct by 29% ( P <.05). Aminoguanidine or l -arginine did not influence the increase in water content in the postischemic brain, indicating that the effect on infarct volume is not related to modulation of ischemic edema. Conclusions These results demonstrate that cerebral ischemia is also associated with iNOS expression in a minimally invasive model of transient MCA occlusion and that iNOS inhibition reduces focal ischemic damage. The findings support the hypothesis that nitric oxide produced by iNOS contributes to ischemic brain damage and that inhibition of iNOS may be a valuable tool in the management of cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Cited by
Bright and dark sides of nitric oxide in ischemic brain injury
Iadecola, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10074-6 · Cited by 1,046
Self-citationRegulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780
Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage
Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02746.1997 · Cited by 716
Self-citationOxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Nitric Oxide Synthase in Models of Focal Ischemia
Samdani, A. F., Dawson, T. M., & Dawson, V. L. (1997) · Stroke · doi:10.1161/01.str.28.6.1283 · Cited by 656
Metadata
- Authors
- Zhang, F., Casey, R. M., Ross, M. E., & Iadecola, C.
- Venue
- Stroke
- Published
- 1996-02
- Volume
- 27
- Issue
- 2
- Pages
- 317-323
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2024556319
- Cited by
- 181
- References
- 1
- FWCI
- 18.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aminoguanidine Ameliorates and l -Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery Occlusion. https://app.cochat.ai/papers/10.1161/01.str.27.2.317
- The paper
- Zhang, F., Casey, R. M., Ross, M. E., & Iadecola, C. (1996). Aminoguanidine Ameliorates and l -Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery Occlusion. Stroke. https://doi.org/10.1161/01.str.27.2.317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.